Ultra Market Research | Global Artificial lung market
Global Artificial lung market
Report ID : 782
Category : Healthcare-Companies
No Of Pages : 143
Published on: October 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Introduction
Global Artificial Lung Market is a dynamic sector focusing on the development and implementation of artificial lung devices, designed to support patients suffering from severe respiratory failure and chronic lung diseases. Artificial lungs serve as life-support systems that oxygenate the blood and remove carbon dioxide, simulating natural lung functions. Their applications span across intensive care units (ICUs), long-term respiratory management, and emergency medical settings. With growing respiratory health issues and advancements in biotechnology, artificial lung technologies are rapidly evolving. Recent trends indicate a strong movement towards portable and wearable artificial lung devices, aiming to improve patient mobility and quality of life. This market growth is spurred by a demand for innovative, life-saving respiratory support solutions, with artificial lung systems seeing increased adoption globally.
Segmentation
By Devices Portable Devices Pediatric Adult Neonatal Others Stationary Devices Hybrid Systems ECMO Machines
By Applications Acute Respiratory Distress Hospital Use Home Care Emergency Care Others Chronic Obstructive Pulmonary Disease (COPD) Cystic Fibrosis Lung Transplantation Support Others
By End Users Hospitals Intensive Care Units Emergency Departments Others Homecare Settings Specialty Clinics Academic and Research Institutions Others
Drivers The Global Artificial Lung Market is propelled by an increasing prevalence of chronic respiratory conditions, including Chronic Obstructive Pulmonary Disease (COPD), acute respiratory distress syndrome, and COVID-19-related complications. An aging population and heightened air pollution levels contribute to rising cases of lung disorders, subsequently boosting the need for artificial lung technologies. Technological advancements, such as portable artificial lungs, are another driving factor, enabling patients to move outside of ICU environments, enhancing mobility and quality of life. Research and development investments are enhancing product efficacy and expanding treatment capabilities, allowing artificial lungs to be utilized in new therapeutic scenarios. Supportive governmental initiatives and an emphasis on improving patient survival rates further drive the growth of the artificial lung market globally.
Restraints Despite the promising growth outlook, several factors challenge the expansion of the Global Artificial Lung Market. High costs associated with artificial lung systems and their maintenance pose a significant barrier for hospitals and healthcare facilities, particularly in emerging economies. Moreover, the complexity of artificial lung devices requires specialized healthcare providers and trained technicians, limiting accessibility in regions with limited healthcare infrastructure. The potential risks associated with artificial lungs, including infection, blood clots, and device-related complications, can also impact patient and provider adoption rates. Stringent regulatory policies and lengthy product approval processes further limit rapid product deployment, hampering the market's growth potential.
Opportunities The artificial lung market presents numerous opportunities for expansion, particularly through innovation in wearable and compact devices, addressing the need for respiratory support with greater patient mobility. Increasing awareness about the advantages of artificial lungs in managing severe respiratory conditions has opened avenues for their application in home care settings, catering to patients who prefer remote care. Emerging markets in Asia and Latin America are witnessing a rise in healthcare spending, paving the way for artificial lung adoption as awareness and resources grow. Technological advancements in artificial intelligence (AI) and machine learning (ML) also hold the potential to enhance patient outcomes by optimizing device functionality in real-time, creating vast growth opportunities in the market.
Trends The Global Artificial Lung Market is seeing an evolution toward wearable and less invasive devices, aiming to minimize patient dependency on large ICU systems. One key trend is the integration of ECMO (extracorporeal membrane oxygenation) technology with artificial lungs, allowing them to support patients with acute respiratory failure efficiently. Moreover, there is a shift toward compact, user-friendly devices designed for homecare use, reflecting the broader trend of decentralizing healthcare and providing support in non-hospital settings. Advances in biomaterials used in artificial lungs have significantly improved device durability and biocompatibility, reducing patient complications. These advancements underscore the market’s focus on creating adaptable, patient-centered solutions that can integrate seamlessly into different care settings.
List of Market Players
ALung Technologies Inc. (United States)
Getinge AB (Sweden)
Medtronic PLC (Ireland)
Abbott Laboratories (United States)
A Lung Inc. (United States)
Xenios AG (Germany)
Breethe, Inc. (United States)
Hemolung Technologies Inc. (United States)
Avalon Laboratories (United States)
Eurosets Srl (Italy)
LivaNova PLC (United Kingdom)
Novalung GmbH (Germany)
Fresenius Medical Care AG & Co. (Germany)
Terumo Corporation (Japan)
Nipro Corporation (Japan)
Key Target Audience
Hospitals and Intensive Care Units
Home Care Providers
Specialty Clinics and Rehabilitation Centers
Academic and Research Institutions
Medical Device Manufacturers and Suppliers
Regulatory and Healthcare Governing Bodies
An artificial lung is a medical device that simulates natural lung functions by oxygenating blood and removing carbon dioxide, providing respiratory support for patients with severe lung diseases.
Major drivers include the increasing prevalence of chronic respiratory diseases, technological advancements, and growing demand for portable, patient-friendly respiratory solutions.
The market faces challenges such as high device costs, stringent regulatory standards, and the need for specialized healthcare providers to operate the systems.
Yes, modern innovations have led to the development of portable artificial lungs that are more suitable for homecare settings, though patients still require regular medical monitoring.
North America and Europe currently dominate, but regions like Asia-Pacific are witnessing high growth due to increased healthcare spending and rising awareness about respiratory care solutions.
Executive Summary
Market Overview
Key Findings
Recommendations
Research Methodology
Data Collection Methods
Research Approach
Scope and Limitations
Market Dynamics
Drivers
Restraints
Opportunities
Market Trends
Market Segmentation
By Product Type
Extracorporeal Membrane Oxygenation (ECMO)
Intraoperative Lung Support Systems
Portable Artificial Lung Devices
By Technology
Membrane Oxygenators
Microfluidic Devices
By Application
Hospital Use
Ambulatory Surgical Centers
Home Care
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Competitive Landscape
Market Share Analysis
Key Market Players
Company Profiles
Business Overview
Financial Overview
Product Portfolio
Recent Developments
SWOT Analysis
Market Analysis by Region
North America
Market Size & Forecast
Key Trends and Drivers
Europe
Market Size & Forecast
Key Trends and Drivers
Asia-Pacific
Market Size & Forecast
Key Trends and Drivers
Latin America
Market Size & Forecast
Key Trends and Drivers
Middle East & Africa
Market Size & Forecast
Key Trends and Drivers
Market Opportunities and Future Prospects
Emerging Applications and Technological Advancements
Strategic Initiatives by Key Players
Market Expansion Opportunities
Target Audience and Recommendations
Key Stakeholders
Strategic Recommendations
Appendix
Abbreviations and Glossary
Methodology Overview
References
List of Tables
Global Artificial Lung Market, Key Findings (2024-2032)
Global Artificial Lung Market Segmentation by Product Type (2024-2032)
Artificial Lung Market by Technology (2024-2032)
Artificial Lung Market by Application (2024-2032)
Regional Market Size for Artificial Lung by Region (2024-2032)
Competitive Landscape – Market Share of Key Players (2024)
Company Profiles – Product Portfolio of Major Players
Market Drivers and Restraints Analysis
Emerging Trends in the Artificial Lung Market
Strategic Initiatives of Leading Market Players
Regional Breakdown – Key Drivers and Restraints for Major Regions
Projected Market Opportunities by Region and Segment (2024-2032)
Future Prospects and Technological Advancements in Artificial Lung Market
Recommended Actions for Key Stakeholders
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Artificial lung market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Artificial lung market for the past year and forecasts for the next six years. Global Artificial lung market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Artificial lung market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Artificial lung market from different application industries in different regions.
Segmentation
By Devices Portable Devices Pediatric Adult Neonatal Others Stationary Devices Hybrid Systems ECMO Machines
By Applications Acute Respiratory Distress Hospital Use Home Care Emergency Care Others Chronic Obstructive Pulmonary Disease (COPD) Cystic Fibrosis Lung Transplantation Support Others
By End Users Hospitals Intensive Care Units Emergency Departments Others Homecare Settings Specialty Clinics Academic and Research Institutions Others
